Literature DB >> 31038354

Developmental Consequences of Prenatal Substance Use in Children and Adolescents.

Constance Guille1,2, Rubin Aujla1.   

Abstract

Objective: Prenatal substance use is increasing and is a major public health concern due to its impact on women's health and child development. Prior studies demonstrate an association between prenatal substance use and deficits in children's physical, cognitive, behavioral, and emotional development. Many studies, however, have significant methodological limitations that hinder our understanding of the impact of substance use on child development. The goal of this review is to describe the risks of prenatal substance use on child development among studies that have overcome major study limitations to inform the development of targeted interventions to improve child health.
Methods: Studies investigating the relationship between prenatal substance use and its impact on child development are identified. Studies employing a prospective, longitudinal study design with appropriate comparison groups and methods accounting for potentially confounding variables are reviewed.
Results: Prenatal tobacco or alcohol use has the most well-established adverse impact on child development, including an increased risk for behavioral problems and deficits in academic performance, resulting in significant functional impairment. Prenatal marijuana use is associated with deficits in executive and intellectual functioning among school-age children and adolescents. Prenatal opioid use and child development findings are conflicting, but treatment with opioid agonist therapy for opioid use disorder (e.g., methadone or buprenorphine) does not appear to have a negative impact on child growth, cognition, language abilities, sensory processing, or temperament. Prenatal amphetamine and cocaine use may have a negative impact on child development, but effects, in part, are mediated by childhood environment and adversity. Conclusions: Preventative efforts in women's health are needed to reduce substance use and unplanned pregnancies. Early interventions for children exposed to substances are needed as well as interventions targeting the myriad of issues that co-occur with substance use, including poverty, mental health problems, and childhood adversity.

Entities:  

Keywords:  child and adolescent development; pregnancy; prenatal substance use

Year:  2019        PMID: 31038354     DOI: 10.1089/cap.2018.0177

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN: 1044-5463            Impact factor:   2.576


  7 in total

1.  Leveraging Telehealth in the United States to Increase Access to Opioid Use Disorder Treatment in Pregnancy and Postpartum During the COVID-19 Pandemic.

Authors:  Constance Guille; Jenna L McCauley; Angela Moreland
Journal:  Am J Psychiatry       Date:  2021-04-01       Impact factor: 18.112

2.  Marijuana use in Pregnant Women with Disabilities in the United States.

Authors:  Panagiota Kitsantas; Salman M Aljoudi; Gilbert Gimm
Journal:  Matern Child Health J       Date:  2022-01-04

3.  Prenatal PM2.5 exposure and infant temperament at age 6 months: Sensitive windows and sex-specific associations.

Authors:  Fataha Rahman; Brent A Coull; Kecia N Carroll; Ander Wilson; Allan C Just; Itai Kloog; Xueying Zhang; Rosalind J Wright; Yueh-Hsiu Mathilda Chiu
Journal:  Environ Res       Date:  2021-12-17       Impact factor: 6.498

4.  Gender, Addiction, and Removal of Children Into Care.

Authors:  Lynda Russell; Ruchika Gajwani; Fiona Turner; Helen Minnis
Journal:  Front Psychiatry       Date:  2022-06-02       Impact factor: 5.435

Review 5.  Prenatal drug exposure and neurodevelopmental programming of glucocorticoid signalling.

Authors:  Alexis L Franks; Kimberly J Berry; Donald B DeFranco
Journal:  J Neuroendocrinol       Date:  2019-10-02       Impact factor: 3.870

Review 6.  Growth and Neurodevelopment of HIV-Exposed Uninfected Children: a Conceptual Framework.

Authors:  Catherine J Wedderburn; Ceri Evans; Shunmay Yeung; Diana M Gibb; Kirsten A Donald; Andrew J Prendergast
Journal:  Curr HIV/AIDS Rep       Date:  2019-12       Impact factor: 5.071

7.  Infant neurodevelopmental outcomes of prenatal opioid exposure and polysubstance use.

Authors:  Madelyn H Labella; Rina D Eiden; Alexandra R Tabachnick; Tabitha Sellers; Mary Dozier
Journal:  Neurotoxicol Teratol       Date:  2021-06-08       Impact factor: 4.071

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.